ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,889 | -5,019 | -2,445 | -5,959 | -4,300 |
| Depreciation Amortization | 75 | 49 | 23 | 93 | 70 |
| Other Working Capital | 389 | 363 | 295 | 151 | -99 |
| Other Operating Activity | 485 | 397 | 294 | 193 | 189 |
| Operating Cash Flow | $-6,940 | $-4,211 | $-1,833 | $-5,522 | $-4,140 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,047 | N/A | N/A | N/A | N/A |
| PPE Investments | -72 | -62 | -30 | -9 | -5 |
| Investing Cash Flow | $-12,119 | $-62 | $-30 | $-9 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,454 | 18,112 | 992 | 9,782 | 9,657 |
| Financing Cash Flow | $18,454 | $18,112 | $992 | $9,782 | $9,657 |
| Beginning Cash Position | 9,134 | 9,134 | 9,134 | 4,884 | 4,884 |
| End Cash Position | 8,530 | 22,973 | 8,263 | 9,134 | 10,396 |
| Net Cash Flow | $-605 | $13,839 | $-872 | $4,251 | $5,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,940 | -4,211 | -1,833 | -5,522 | -4,140 |
| Capital Expenditure | -72 | -62 | -30 | -9 | -5 |
| Free Cash Flow | -7,012 | -4,273 | -1,864 | -5,531 | -4,145 |